Baird Medical Investment Holdings (BDMD) Profit After Tax (2024 - 2025)
Baird Medical Investment Holdings' (BDMD) quarterly Profit After Tax came in at $35.6 million in Q2 2025, down 10.27% on a QoQ basis from $39.7 million in Q4 2024.
Baird Medical Investment Holdings (BDMD) Profit After Tax (2024 - 2025) Analysis & Trends
Baird Medical Investment Holdings (BDMD) has 2 years of Profit After Tax data on file, last reported at $35.6 million in Q2 2025.
- On a quarterly basis, Profit After Tax changed N/A year-over-year to $35.6 million in Q2 2025; TTM through Jun 2025 was $35.6 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$27.5 million, down 169.44% from the prior year.
- Profit After Tax for Q2 2025 stood at $35.6 million, down from $39.7 million in the prior quarter.
- Over the last five years, Profit After Tax for BDMD reached as high as $39.7 million in Q4 2024 and fell as low as $35.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 170.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Baird Medical Investment Holdings | 30.57 Mn | 30.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 35.59 Mn |
| Dec 31, 2024 | 39.66 Mn |